Related Experiment Video
Updated: Apr 27, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Modification of Microbial Polymalic Acid With Hydrophobic Amino Acids for Drug-Releasing Nanoparticles
Alberto Lanz-Landázuri1, Montserrat García-Alvarez1, José Portilla-Arias2
1Departament d'Enginyeria Química, Universitat Politècnica de Catalunya, ETSEIB, Diagonal 647, 08028, Barcelona, Spain.
Abstract:
Microbial poly(β, l-malic acid) was modified with either l-leucine ethyl ester (L) or l-phenylalanine methyl ester (F) to produce amphiphylic copolymers. The degradation of these copolymers in aqueous buffer took place under physiological conditions in a few weeks by hydrolysis of the side chain ester group followed by cleavage of the main chain. Spherical nanoparticles with diameters ranging between 70 and 230 nm were prepared from these copolymers by the dialysis-precipitation method. No alteration of the cell viability was observed after incubation of these nanoparticles in different cell lines. Anticancer drugs temozolomide and doxorubicin were encapsulated in the nanoparticles. Temozolomide was released within several hours whereas doxorubicin took several weeks to be completely liberated.
Insights
Biodegradable nanoparticles were synthesized from microbial poly(β, l-malic acid) and amino acid esters. These biocompatible nanoparticles effectively encapsulated and released anticancer drugs, showing potential for drug delivery applications.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Nanotechnology
Background:
- Microbial poly(β, l-malic acid) is a biodegradable polymer with potential applications in drug delivery.
- Developing amphiphilic copolymers is crucial for creating effective nanoparticle drug delivery systems.
Purpose of the Study:
- To synthesize and characterize amphiphilic copolymers from microbial poly(β, l-malic acid) and amino acid esters.
- To prepare and evaluate the biocompatibility of nanoparticles derived from these copolymers.
- To assess the drug loading and release profiles of anticancer drugs encapsulated within these nanoparticles.
Main Methods:
- Modification of poly(β, l-malic acid) with l-leucine ethyl ester or l-phenylalanine methyl ester.
- Preparation of nanoparticles using the dialysis-precipitation method.
- In vitro cell viability assays.
- Drug encapsulation and release studies with temozolomide and doxorubicin.
Main Results:
- Amphiphilic copolymers were successfully synthesized and degraded under physiological conditions.
- Spherical nanoparticles (70-230 nm) were formed with no observed cytotoxicity.
- Differential release rates were observed for temozolomide (hours) and doxorubicin (weeks).
Conclusions:
- The synthesized copolymers form safe and effective nanoparticles for drug delivery.
- The nanoparticles exhibit tunable drug release kinetics, suitable for different therapeutic needs.
- These biodegradable nanoparticles represent a promising platform for cancer therapy.
Related Concept Videos
Modified-Release Drug Delivery Systems: Stimuli-Activated
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Rate-Programmed II

